Akèy › Kansè nan tete › Texas › League City
Etid klinik pou Kansè nan tete nan League City, TX
12 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote League City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Ap rekriteFaz 1
- NEXT Houston, Galveston · 23 mi lwen
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- Tranquility Research, Webster · 3 mi lwen
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- Tranquil Clinical Research, Webster · 3 mi lwen
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- UT MD Anderson - League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi lwen
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Ap rekriteFaz 2
- Tranquil Clinical Research, Webster · 3 mi lwen
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Ap rekriteFaz 3
- MD Anderson League City, League City
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- MD Anderson League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi lwen
- University of Texas Medical Branch, Galveston · 23 mi lwen
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Ap rekriteEtid obsèvasyon
- MD Anderson League City, Nassau Bay · 3 mi lwen
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Ap rekrite
- University of Texas Medical Branch at Galveston, TX, Galveston · 23 mi lwen
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
Ap rekriteVolontè an sante akeyi
- The University of Texas Medical Branch, Galveston, Galveston · 23 mi lwen
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Ap rekriteEtid obsèvasyon
- University of Texas Medical Branch, League City
- Texas Oncology - Webster, Webster · 3 mi lwen
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan League City
- Kansè Poumon ki pa ti selil15 etid
- Kansè Metastatik7 etid
- Kolit Ulseratif6 etid
- Kansè poumon6 etid
- Kansè kolorektal6 etid
- Kansè (tout kalite)5 etid
- Kansè ovè5 etid
- Akidan serebavaskilè5 etid
- Kansè vejik4 etid
- Karsinòm selil skuamèz tèt ak kou4 etid
- Kansè pwostat4 etid
- Kondisyon Post-COVID (Long COVID)3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.